Headaches and dizziness Headaches are reported by a significant minority of patients, particularly early in treatment
Originally developed for managing blood glucose levels in people with type 2 diabetes, GLP-1 receptor agonists like Ozempic have demonstrated impressive results in supporting healthy weight loss
According to the telehealth consent published by OpenLoop Healthcare Partners, PC, the licensed medical group partnering with FeelGood, the FDA does not approve, review, or evaluate compounded medications for safety, effectiveness, or quality
Newer medications are designed to activate both GLP-1 and GIP receptors at the same time, which may provide a stronger effect on appetite regulation and metabolic health
Remember that patience pays off in real ways for your long term health, because even modest weight loss can decrease your risk of heart disease, diabetes, and many more challenges
Fall risk assessment should be included in the monitoring protocol, as rapid weight loss can affect balance and bone density
